Status:

COMPLETED

Effects of Worksite Wellness Interventions on Vascular Function, Insulin Sensitivity and High-Density Lipoprotein in Overweight or Obese Women

Lead Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Atherosclerosis

Diabetes Mellitus

Eligibility:

FEMALE

18+ years

Phase:

PHASE2

Brief Summary

Employees in developed societies are becoming increasingly sedentary at work and at home due to technological advances. Physical inactivity coupled with excess intake of calorie-rich foods are respons...

Detailed Description

Employees in developed societies are becoming increasingly sedentary at work and at home due to technological advances. Physical inactivity coupled with excess intake of calorie-rich foods are respons...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • Female employees of NIH who are not currently participating or greater than 3 months from participation in the Keep the Beat program or other structured exercise or weight-loss program (e.g., Weight Watchers, NutriSystems, personalized nutritional counseling or fitness trainers), and have not undergone weight loss (bariatric) surgery. Self-directed exercise (walks around the block, climbing stairs) is acceptable for inclusion, with subjects encouraged to continue such activity, in addition to worksite exercise, throughout the program.
  • Body-mass index greater than or equal to 25 kg/m(2).
  • Subject understands protocol and provides written, informed consent in addition to willingness to comply with specified follow-up evaluations.
  • EXCLUSION CRITERIA:
  • Medical condition, including recent unintentional weight loss, that might prohibit safe participation in the Keep the Beat program.
  • Fluctuation in weight greater than 5 percent over previous 3 months by self report.
  • Fasting blood glucose greater than or equal to 126 mg/dL in absence of prior diagnosis of diabetes mellitus.
  • Weight greater than 200 kg (exceeds capacity of DXA scanner).
  • Heart disease as indicated by history of myocardial infarction, documented disease on coronary angiography, coronary artery stent placement, congestive heart failure, significant structural heart disease (e.g. hypertrophic or dilated cardiomyopathy, valvular heart disease).
  • Hyper- or hypothyroid by routine lab screening.
  • Physically unable to perform the Keep the Beat program due to neurologic or orthopedic conditions.
  • Pregnant women due to large hormonal changes in pregnancy that affect study variables and potential pregnancy-related restrictions on exercise.
  • Participation in another study protocol which includes blood draws or interventions.
  • Use of medications that might interfere with, or promote, weight loss.

Exclusion

    Key Trial Info

    Start Date :

    April 8 2008

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    November 1 2012

    Estimated Enrollment :

    270 Patients enrolled

    Trial Details

    Trial ID

    NCT00666172

    Start Date

    April 8 2008

    End Date

    November 1 2012

    Last Update

    December 17 2019

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institutes of Health Clinical Center, 9000 Rockville Pike

    Bethesda, Maryland, United States, 20892